Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Women's Oncology Review

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14733400400013030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Skin sparing mastectomy and immediate breast reconstruction.

  2005cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

  2002cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

  2000cited by this paper
• Genetic and hormonal risk factors in breast cancer.

  2000cited by this paper
• Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

  1999cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Autologous breast reconstruction with use of transverse rectus abdominis musculocutaneous flap: Mayo clinic experience with 147 cases.

  1994cited by this paper

• Anticipation of deteriorating health and information avoidance.

  2023cites this paper
• Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting

  2022cites this paper
• Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.

  2020cites this paper
• Therapeutic implications of germline genetic findings in cancer

  2019cites this paper
• Factors influencing diagnosis and outcome in HER2 receptor positive breast cancer

  2019cites this paper
• Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation

  2018cites this paper
• Accurate classification of BRCA1 variants with saturation genome editing

  2018cites this paper
• Accurate functional classification of thousands of BRCA1 variants with saturation genome editing

  2018cites this paper
• Genetic screening for gynecological cancer: where are we heading?

  2016cites this paper
• Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center mes in 41 Patients Postsurgical Outco

  2016cites this paper
• Identification of the genetic basis of multicentric tumourigenesis

  2016cites this paper
• Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations

  2015cites this paper
• Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference?

  2015cites this paper
• Breast Cancer Genetics and Risk Assessment

  2015cites this paper
• Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

  2015cites this paper
• Evaluating Changes in Patient Anxiety Regarding Classic Cancer Genetic Testing Versus Expanded Multiplex Cancer Genetic Testing

  2015cites this paper
• Rates of risk‐reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers

  2014cites this paper
• [Risk-adapted surveillance: focus on familial breast and ovarian cancer].

  2014cites this paper
• [Genetical aspects of surgical treatment in patients with hereditary breast cancer].

  2014cites this paper
• Oncoplastic surgery in the treatment of breast cancer

  2013cites this paper
• Meta-Analysis of Genetic Associations Using Knowledge Representation

  2013cites this paper
• Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?

  2013cites this paper
• Breast cancer in BRCA mutation carriers: breast-conserving therapy or bilateral mastectomy?

  2013cites this paper
• Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer.

  2012cites this paper
• The management of menopausal symptoms in breast cancer survivors: case-based approach.

  2012cites this paper
• Management Updates for Women with a BRCA1 or BRCA2 Mutation

  2012cites this paper
• Reducing the risk of breast cancer: A personalized approach.

  2012cites this paper
• Knowledge, Attitudes, and Utilization of BRCA Testing Among Obstetricians and Gynecologists

  2012cites this paper
• Targeted therapy in breast cancer: what's new?

  2011cites this paper
• ManagementofWomenWith BRCA Mutations A 41-Year-Old Woman With a BRCA Mutation and a Recent History of Breast Cancer

  2011cites this paper
• When is contralateral mastectomy warranted in unilateral breast cancer?

  2011cites this paper
• Management of women with BRCA mutations: a 41-year-old woman with a BRCA mutation and a recent history of breast cancer.

  2011cites this paper
• Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

  2011cites this paper
• Therapeutic approaches for women predisposed to breast cancer.

  2011cites this paper
• BRCA mutations in the management of breast cancer: the state of the art

  2010cites this paper
• Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia.

  2010cites this paper
• Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

  2010cites this paper
• Das familiäre Mammakarzinom

  2010cites this paper
• Choice of Management of Southern Chinese BRCA Mutation Carriers

  2010cites this paper
• Prophylactic Mastectomy in High Risk Patients: A Practice-Based Review of the Indications. Do We Follow Guidelines?

  2010cites this paper
• Detection of BRCA1 and BRCA2 mutations in a selected Hawaii population.

  2010cites this paper
• Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

  2009cites this paper
• Socioeconomic status and quality of life of women with family history of breast cancer attending an oncogenetic counseling clinic – a comparison with general population

  2009cites this paper
• Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent

  2009cites this paper
• Targeted Tailored Management of the Breast Cancer Patient at Risk for Harboring a Germline Mutation—Current Trends Affecting the Selection of Patients Considering Surgical Prophylaxis for Breast Cancer

  2009cites this paper
• Genetic Testing for Cancer Susceptibility: How and When?

  2009cites this paper
• Effective preventive treatments for hereditary breast cancer

  2008influential citation
• The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk

  2008cites this paper
• Familial Breast Cancer: Detection of Prevalent High-Risk Epithelial Lesions

  2008cites this paper
• Sentinel Lymph Node Surgery During Prophylactic Mastectomy (Methodology)

  2008cites this paper
• Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment

  2008cites this paper
• Genetic testing in diverse populations: are researchers doing enough to get out the correct message?

  2007cites this paper
• Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist

  2007cites this paper
• MANAGEMENT OF WOMEN AT HIGH FAMILIAL RISK FOR BREAST AND OVARIAN CANCER

  2007cites this paper
• Surgical management of breast cancer.

  2007cites this paper
• What Women Wish They Knew Before Prophylactic Mastectomy

  2007cites this paper
• Breast cancer prevention in women with a BRCA1 or BRCA2 mutation

  2007cites this paper
• Cancer screening in older adults in an era of genomics and longevity.

  2006cites this paper
• Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

  2006cites this paper
• Risk prediction models for familial breast cancer.

  2006cites this paper
• Genetische Beratung bei gynäkologischen Erkrankungen

  2006cites this paper
• Breast cancer susceptibility testing: past, present and future

  2006cites this paper
• Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2.

  2005cites this paper
• Dynamic Magnetic Resonance Imaging in Breast Cancer

  2005cites this paper
• Mutation detection, interpretation, and applications in the clinical laboratory setting.

  2005cites this paper
• What's new in surgical oncology.

  2005cites this paper
• Knowledge, Attitudes, and Utilization of BRCA1/2 Testing among Women with Early-Onset Breast Cancer

  2005cites this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cites this paper